The Digital Foundation

for Modern Clinical Trials

Medigen™ is an integrated EDC and CTMS platform built to support clinical programs of any complexity, combining clinical expertise, regulatory insight, and AI-powered analytics.

Designed by clinical and regulatory experts, Medigen™ enables approval-ready data capture and real-time trial oversight, turning trial results into regulatory-grade evidence to accelerate your medical innovations.

A doctor using a tablet with Medigen suite Icon overlayed

| Built for global | trials. Designed | for approval.

Medigen™ brings together data and image capture, trial execution and monitoring, and GCP oversight in a single intelligent platform.

By connecting data, operations, and compliance in real time, it enables smarter decisions, faster execution, and regulatory-grade evidence from first patient to market approval.

Maptrial™ CTMS+

Discover Trial Operations Intelligence

Maptrial is Meditrial’s clinical trial management system, providing a comprehensive view of trial operations across all sites and countries.

Catchtrial™ EDC+

Discover Clinical Data Intelligence

Catchtrial is Meditrial’s electronic data capture and image capture platform, designed for studies that require structured clinical data alongside imaging, device outputs, and specialized endpoints.

Catchtrial™ Apps+

Discover Outcomes Intelligence

Medigen Suite includes native tools to support modern patient engagement and decentralized trial models.

Everything You Need at Your Fingertips

Medigen Suite connects every aspect of a clinical study
into a single operational ecosystem:

Upholding the Highest Compliance Standards

Medigen Suite is designed around global regulatory and quality standards, including:

Every data point, signature, workflow, and change is fully traceable and audit-ready, supporting confident regulatory submissions and inspections.

Powered by Meditrial’s Clinical & Regulatory Expertise

Medigen Suite reflects Meditrial’s decades of experience running complex global clinical trials.

The platform is continuously shaped by:

  • Medical and regulatory experts
  • Biostatistics and data science teams
  • Ongoing international studies

  • Interactions with regulators and notified bodies

This ensures the Suite evolves in alignment with real-world clinical and regulatory expectations.

A Platform That Scales
with Your Study

Whether supporting an early feasibility trial or a large, multinational pivotal program, Medigen Suite adapts to:

  • Study size and complexity

  • Site and country expansion

  • Hybrid and decentralized models

  • Evolving regulatory requirements

All within one unified, validated platform.